Package Leaflet: Information for the User
Losartan/Hydrochlorothiazide Pensa 100 mg/25 mg Film-Coated Tablets
Read this leaflet carefully before you start taking this medicine.
1. What Losartan/Hydrochlorothiazide Pensa is and what it is used for
2. Before taking Losartan/Hydrochlorothiazide Pensa
3. How to take Losartan/Hydrochlorothiazide Pensa
4. Possible side effects
5. Storage of Losartan/Hydrochlorothiazide Pensa
6. Further information
Losartán/Hidroclorotiazida Pensais a combination of an angiotensin II receptor antagonist(losartán) and a diuretic (hidroclorotiazida).
Losartán/Hidroclorotiazida Pensais indicated for the treatment of essential hypertension (high blood pressure).
Do not take Losartán/Hidroclorotiazida Pensa:
Be especially careful with Losartán/Hidroclorotiazida Pensa:
Inform your doctor if you are pregnant (or if you suspect that you may be). Losartán/Hidroclorotiazida Pensa is not recommended for use at the start of pregnancy, and it should not be taken if you are more than 3 months pregnant as it may cause serious harm to your baby when administered from that time onwards (see Pregnancy section).
Consult your doctor or pharmacist before starting to take Losartán/Hidroclorotiazida Pensa:
Your doctor may monitor your kidney function, blood pressure and electrolyte levels in the blood (e.g. potassium) at regular intervals.
See also the information under the heading “Do not take Losartán/Hidroclorotiazida Pensa”.
Other medicines
Inform your doctor or pharmacist if you are taking or have recently taken other medicines, including those purchased without a prescription.
Diuretics such as hydrochlorothiazide contained in Losartán/Hidroclorotiazida Pensa may interact with other medicines. Preparations containing lithium should not be taken with Losartán/Hidroclorotiazida Pensa without your doctor's careful monitoring. Special precautions may be necessary (e.g. blood tests) if you take potassium supplements, salt substitutes containing potassium or potassium-sparing medicines, diuretics (urine-producing tablets), some laxatives, medicines for gout treatment, heart rhythm-controlling medicines or diabetes medicines (oral or insulin).
It is also important for your doctor to know if you are taking other blood pressure-lowering medicines, steroids, cancer medicines, pain medicines, fungal infection medicines or arthritis medicines, cholesterol-lowering resins such as cholestyramine, muscle relaxants, sleeping tablets; opioid pain medicines such as morphine, “pressor amines” such as adrenaline or other medicines in the same group; (oral diabetes medicines or insulin).
Your doctor may need to adjust your dose and/or take other precautions.
If you are taking an ACE inhibitor or aliskiren (see also the information under the headings “Do not take Losartán/Hidroclorotiazida Pensa” and “Be especially careful with Losartán/Hidroclorotiazida Pensa”).
Please inform your doctor when you plan to have a contrast agent with iodine.
Losartán/Hidroclorotiazida Pensa with food and drinks
It is recommended that you do not drink alcohol while taking these tablets: alcohol and Losartán/Hidroclorotiazida Pensa tablets may increase the effects of each other.
Excessive salt in the diet may counteract the effect of Losartán/Hidroclorotiazida Pensa tablets.
Losartán/Hidroclorotiazida Pensa tablets can be taken with or without food.
Pregnancy and breastfeeding:
Pregnancy
You must inform your doctor if you are pregnant (or if you suspect that you may be). Your doctor will usually recommend that you stop taking Losartán/Hidroclorotiazida Pensa before becoming pregnant or as soon as you know you are pregnant and will recommend that you take another medicine instead of Losartán/Hidroclorotiazida Pensa. Losartán/Hidroclorotiazida Pensa is not recommended for use at the start of pregnancy, and it should not be taken if you are more than 3 months pregnant as it may cause serious harm to your baby when administered from that time onwards.
Breastfeeding
Inform your doctor if you are breastfeeding or plan to start breastfeeding. Losartán/Hidroclorotiazida Pensa is not recommended for use during breastfeeding, and your doctor will choose another treatment for you if you wish to breastfeed.
Consult your doctor or pharmacist before using any medicine.
Use in children and adolescents
There is no experience with the use of Losartán/Hidroclorotiazida in children. Therefore, Losartán/Hidroclorotiazida Pensa should not be administered to children.
Use in elderly patients
Losartán/Hidroclorotiazida Pensa acts with equal efficacy and is equally well tolerated by most elderly and young patients. Most elderly patients require the same dose as younger patients.
Driving and operating machinery
When starting treatment with this medicine, you should not perform tasks that may require special attention (e.g. driving a car or using hazardous machinery) until you know how you tolerate your medicine.
Important information about some of the components of Losartán/Hidroclorotiazida Pensa
This medicine contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with him before taking this medicine.
Use in athletes:
This medicine contains hydrochlorothiazide, which may produce a positive result in doping control tests.
Follow exactly the administration instructions for Losartán/Hidroclorotiazida Pensa, as indicated by your doctor. Your doctor will decide the appropriate dose of Losartán/Hidroclorotiazida Pensa, depending on your condition and if you are taking other medications. It is essential to continue taking Losartán/Hidroclorotiazida Pensa as prescribed by your doctor to maintain consistent blood pressure control.
Hypertension
For most patients with high blood pressure, the usual dose is one tablet of losartan/hidroclorotiazida 50 mg/12.5 mg per day to control blood pressure for 24 hours. The dose may be increased to one tablet of losartan/hidroclorotiazida 100 mg/25 mg (a stronger dose) per day. The maximum daily dose is one tablet of 100 mg of losartan/25 mg of hidroclorotiazida per day.
If you take more Losartán/Hidroclorotiazida Pensa than you should
In case of an overdose, contact your doctor immediately or go directly to the hospital for immediate medical attention. An overdose may cause a drop in blood pressure, palpitations, slow pulse, changes in blood composition, and dehydration.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to take Losartán/Hidroclorotiazida Pensa
Try to take Losartán/Hidroclorotiazida Pensa at the same time each day as prescribed. However, if you miss a dose, do not take an extra dose. Simply return to your regular schedule.
Like all medicines, Losartán/Hidroclorotiazida Pensa can cause side effects, although not everyone will experience them.
If you experience the following, stop taking the Losartán/Hidroclorotiazida Pensa tablets
Pensa and inform your doctor immediately or go to the nearest hospital emergency department:
A severe allergic reaction (skin rash, itching, swelling of the face, lips, mouth, or throat that may cause difficulty swallowing or breathing).
This is a serious but rare side effect that affects more than 1 in 10,000 patients but less than 1 in 1,000. You may need urgent medical attention or hospitalization.
The following side effects have been reported:
Frequent (affecting fewer than 1 in 10 but more than 1 in 100):
Less frequent (affecting fewer than 1 in 100 but more than 1 in 1,000):
Rare (affecting more than 1 in 10,000 and fewer than 1 in 1,000):
Very rare (affecting fewer than 1 in 10,000 patients):
Frequency not known (cannot be estimated from available data).
Reporting side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep out of the reach and sight of children.
Do not useLosartán/Hidroclorotiazida Pensaafter the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Store below30°C.
Store in the original packaging.Keep the blister in the outer packaging. Do not open the blister until ready to take the tablet.
Medicines should not be disposed of through drains or in the trash. Deposit the containers and medicines that you no longer need at the SIGRE point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medicines that you no longer need. In this way, you will help protect the environment.
Composition of Losartán/Hidroclorotiazida Pensa
The active principles are losartan potassium and hidroclorotiazida.
Each Losartán/Hidroclorotiazida Pensa 100 mg/25 mg tablet contains, as active principles, 100 mg of losartan (potassium) and 25 mg of hidroclorotiazida.
Losartán/Hidroclorotiazida Pensa 100 mg/25 mg contains the following inactive ingredients: microcrystalline cellulose, lactose monohydrate, pregelatinized cornstarch, and magnesium stearate (E-572).
Losartán/Hidroclorotiazida Pensa 100 mg/25 mg contains 8.48 mg (0.216 mEq) of potassium.
Losartán/Hidroclorotiazida Pensa 100 mg/25 mg also contains hydroxypropylcellulose, hypromellose, titanium dioxide (E-171), and yellow iron oxide (E-172).
Appearance of the product and contents of the package
Losartán/Hidroclorotiazida Pensa 100 mg/25 mg is supplied as film-coated, yellow, uncoated tablets.
Losartán/Hidroclorotiazida Pensa 100 mg/25 mg is supplied in the following package sizes: Packets of 28 tablets.
Holder of the Marketing Authorization and Responsible for Manufacturing
Holder of the marketing authorization
Towa Pharmaceutical, S.A.
C/ de Sant Martí, 75-97
08107 Martorelles (Barcelona)
Spain
Responsible for manufacturing
Laboratorios Liconsa, S.A.
Avda. Miralcampo, Nº 7, Industrial Estate Miralcampo
19200 Azuqueca de Henares (Guadalajara)
Spain
Last review date of this prospectus:February 2025
The detailed information of this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.